ストックスクリーナーアプリを入手
0.4005
2.55%
-0.0105
前日終値:
$0.411
開ける：
$0.4069
24時間の取引高:
241.89K
Relative Volume:
0.19
時価総額：
$16.27M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-7.51%
1か月 パフォーマンス:
-19.29%
6か月 パフォーマンス:
-62.57%
1年 パフォーマンス:
-85.33%
1日の値動き範囲:
$0.40
$0.422
1週間の範囲:
$0.39
$0.4395
52週間の値動き範囲:
$0.39
$3.61
Scienture Holdings Inc Stock (SCNX) Company Profile
Compare SCNX vs HITI, PETS, POM, WGRX
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SCNX
Scienture Holdings Inc
|
0.4005 | 16.70M | 0 | 0 | 0 | 0.00 |
|
HITI
High Tide Inc
|
2.49 | 210.82M | 376.07M | -22.41M | 18.73M | -0.298 |
|
PETS
Petmed Express Inc
|
2.95 | 64.42M | 270.52M | -6.08M | 17.42M | -0.2944 |
|
POM
Pomdoctor Ltd Adr
|
0.2211 | 27.96M | 0 | 0 | 0 | 0.00 |
|
WGRX
Wellgistics Health Inc
|
0.2275 | 26.22M | 28.99M | -39.20M | -3.34M | 0.00 |
Scienture Holdings Inc (SCNX) 最新ニュース
What are analysts’ price targets for Scienture Holdings Inc.2025 Year in Review & Fast Gaining Stock Reports - mfd.ru
Aug Movers: What is Scienture Holdings Incs market positionWeekly Gains Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
Gainers Report: What is Scienture Holdings Incs market positionBond Market & Weekly Breakout Stock Alerts - baoquankhu1.vn
Why Scienture Holdings Inc. (4E4) stock is upgraded to buyProfit Target & Long-Term Safe Investment Plans - mfd.ru
Is Scienture Holdings Inc. stock a good pick for beginnersJuly 2025 Highlights & Low Risk Profit Maximizing Plans - mfd.ru
Aug Levels: Is Scienture Holdings Inc stock heavily shortedWeekly Profit Analysis & Smart Swing Trading Alerts - baoquankhu1.vn
Scienture reports progress on ARBLI, confirms REZENOPY launch By Investing.com - Investing.com Nigeria
SCNX: Scienture Updates on Arbli and Future Product Launch - GuruFocus
Scienture reports progress on ARBLI, confirms REZENOPY launch - Investing.com
SCIENTURE Provides Commercial Update on ARBLI™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium - The Manila Times
Scienture Provides Commercial Update on ARBLI , the First FDA-Approved Ready-To-Use Oral Suspension of Losartan Potassium - marketscreener.com
Signal Recap: Does InvenTrust Properties Corp stock have upside surprise potentialAnalyst Downgrade & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
Is Scienture Holdings Inc gaining market share2025 Technical Overview & AI Enhanced Trading Signals - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Scienture appoints Hariharan, Mani as co-CEOs - MSN
Growth Value: Will Scienture Holdings Inc benefit from geopolitical trendsWeekly Trading Summary & Comprehensive Market Scan Insights - baoquankhu1.vn
EPS Watch: What is Scienture Holdings Incs book value per share2025 Technical Overview & Expert Approved Momentum Ideas - baoquankhu1.vn
Risk On: Is Scienture Holdings Inc stock heavily shortedMarket Risk Summary & Reliable Entry Point Alerts - baoquankhu1.vn
Will Scienture Holdings Inc. stock recover faster than peersQuarterly Performance Summary & Stepwise Entry and Exit Trade Signals - bollywoodhelpline.com
Aug Spikes: Is EHTH stock forming a cup and handleOil Prices & Free Accurate Trade Setup Notifications - baoquankhu1.vn
EXCLUSIVE: Penny Stock Scienture's Partner Secures US Patent For Highest Dosage Naloxone Spray For Emergency Opioid Overdose Treatment - Sahm
Head to Head Review: Scienture (NASDAQ:SCNX) & Aldeyra Therapeutics (NASDAQ:ALDX) - Defense World
Scienture receives patent for high-dose naloxone nasal spray By Investing.com - Investing.com Nigeria
Scienture And Summit's REZENOPY Awarded Orange Book-Listable Patent, Valid Till 2041 - Nasdaq
SCNX Secures Patent for REZENOPY Nasal Spray Until 2041 - GuruFocus
Scienture receives patent for high-dose naloxone nasal spray - Investing.com
SCIENTURE Announces Issuance of Orange Book-Listable Patent Covering REZENOPY™, the Highest Dosage Naloxone HCl Nasal Spray Approved by the FDA for Life-Saving Opioid Overdose Emergency Treatment - The Manila Times
New patent backs 10 mg naloxone spray for life-saving overdose treatment - Stock Titan
AI Stocks: Will Scienture Holdings Inc stock outperform international peersPortfolio Gains Report & Community Verified Swing Trade Signals - Bộ Nội Vụ
Aug PreEarnings: Will Escalade Incorporated stock hit new highs in YEAR - baoquankhu1.vn
MSN Money - MSN
Scienture Holdings Inc (SCNX) - MSN
Scienture Holdings Inc. (SCNX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Scienture Holdings, Inc.Common Stock (NQ: SCNX - FinancialContent
How buybacks impact Scienture Holdings Inc. stock valuePortfolio Update Summary & Weekly Sector Rotation Insights - Улправда
MarketsMedicine Hat News - FinancialContent
Activity Recap: How buybacks impact Scienture Holdings Inc. stock value2025 Earnings Impact & Daily Chart Pattern Signals - Улправда
Will Scienture Holdings Inc. stock beat EPS estimatesJobs Report & Weekly Watchlist of Top Performers - Улправда
Is Scienture Holdings Inc. stock resilient to inflation2025 Major Catalysts & Weekly Momentum Picks - Улправда
How Scienture Holdings Inc. stock reacts to inflationary pressuresTrade Analysis Summary & High Yield Equity Trading Tips - ulpravda.ru
Why Scienture Holdings Inc. (4E4) stock is favored by hedge funds2025 Major Catalysts & Smart Investment Allocation Tips - ulpravda.ru
Will Scienture Holdings Inc. stock split again soonMarket Growth Report & Real-Time Market Sentiment Reports - ulpravda.ru
Why Scienture Holdings Inc. stock is trending among retail tradersMean Reversion Trades & Explosive Growth Opportunities - Улправда
Will Scienture Holdings Inc stock beat EPS estimates2025 Pullback Review & Weekly Return Optimization Alerts - moha.gov.vn
Scienture Holdings, Inc. (SCNX) - Zacks Investment Research
Scienture Holdings Inc (SCNX) 財務データ
Scienture Holdings Inc (SCNX) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
11.24%
3.75%
大文字化:
|
ボリューム (24 時間):